Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma

National Cancer Institute (NCI) · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
targeted-therapy
mesothelioma, immunotoxin, rapamycin, targeted therapy, mesothelin, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 892039
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.